ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
April 2026
Nuclear Technology
February 2026
Fusion Science and Technology
Latest News
TerraPower announces second Ac-225 production facility
TerraPower Isotopes, a TerraPower subsidiary, plans to increase its actinium-225 production 20-fold by opening a new manufacturing facility in Philadelphia, Pa., and by expanding the capacity of its Everett, Wash., facility. On March 17, TerraPower Isotopes said it expects the new facility to begin producing the medical radioisotope for targeted alpha therapy in 2029.
Yoshiyuki Asaoka, Kunihiko Okano, Tomoaki Yoshida, Ryouji Hiwatari, Seiji Mori
Fusion Science and Technology | Volume 39 | Number 2 | March 2001 | Pages 1018-1022
Safety and Environment | doi.org/10.13182/FST01-A11963376
Articles are hosted by Taylor and Francis Online.
Radioactive waste generated from the CREST reactor has been evaluated. Activation of blankets and shields used during a plant lifetime was evaluated by an activation calculation code taking into accounts of the distribution of neutron wall loading and the scenario of blanket replacement. Limits on surface dose limits define the feasibility of recycling by remote handling (RHR) and by hands-on operation (HOR). After 50 years for decay of activated components, surface dose rate of most of components exceeds 10 mSv/h and cannot be recycled. Some of shields are lower than 10 mSv/h and have a possibility of RHR. After 100 years, surface dose rate of all components is lower than 3 mSv/h, and RHR is feasible. Half of shields are lower than 0.01 mSv/h and have a possibility of HOR. After 125 years, dose rate of all components is lower than 1 mSv/h. RHR with a relatively simple shielding precaution may be feasible. In the cases of 150 years or later, little degradation of dose rate can be expected. Therefore, the used components should be managed within approximately 125 years by suitable methods.